Market Leadership Generis Farmacêutica is the leading generic pharmaceutical brand in Portugal, being the most recognized by consumers and the top treatment provider, which indicates a strong position for expanding distribution channels and introducing complementary health products.

Strategic Acquisition As part of the Aurobindo Group and recently acquired by Aurobindo Pharma USA, Generis benefits from global backing and increased resources, creating opportunities for joint ventures, licensing agreements, and regional expansion initiatives.

Financial Basis With an annual revenue ranging between $25M and $50M, there is significant growth potential to target larger contracts with healthcare providers and government tenders, particularly given its trusted reputation among Portuguese healthcare professionals.

Sustainability Focus Generis emphasizes promoting a sustainable and efficient healthcare system through affordable, high-quality generics, making it an attractive partner for organizations focused on cost-effective solutions and sustainable health initiatives.

Technological Capacity Utilizing a modern tech stack including web development tools and security APIs, Generis is positioned to adopt innovative digital health solutions and enhance e-pharmacy collaborations, creating opportunities for digital engagement and telehealth integration.